Results 231 to 240 of about 184,386 (363)

Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy [PDF]

, 2000
Roland Hetzer, Johannes H. Müller, Yuguo Weng, Matthias Loebe, Gert Wallukat   +4 more
openalex   +1 more source

Smartwatches in the assessment of heart failure patients in epidemiology and pathophysiology studies: A scoping review

ESC Heart Failure, EarlyView.
Abstract A limited number of studies with smartwatches (SWs) investigated their potential in the field of heart failure (HF). The aim of this scoping review is to understand the extent of current literature on SWs in the HF population and the device's potential to improve disease management.
Solenn Fabien, Sandra Waechter, Gbenga A. Kayode, Berno Müller, Marietta Roth, Friedrich Koehler   +5 more
wiley   +1 more source

Myocardial functional recovery following durable ventricular assist device in children. [PDF]

JHLT Open
Langanecha B, Honjo O, Power A, Zaulan O, Haller C, George K, Fazari L, Maurich A, Chiasson D, Jeewa A.   +9 more
europepmc   +1 more source

Portable Pneumatic Biventricular Driver for the Thoratec Ventricular Assist Device

, 1997
David J. Farrar, KEITH E. BUCK, JACK H. COULTER, EDWARD J. KUPA   +3 more
openalex   +1 more source

Single-center experience with the thoratec ventricular assist device [PDF]

, 2000
Reiner Körfer, Aly El‐Banayosy, Latif Arusoglu, Kazutomo Minami, Michael Körner, L. Kizner, O. Fey, U. Schütt, Michiel Morshuis, Herbert Posival   +9 more
openalex   +1 more source

Validation of a biomarker‐based mortality score for cardiogenic shock patients: Comparison with a clinical risk score

ESC Heart Failure, EarlyView.
Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.
Elina Hynninen, Heli Tolppanen, Mercedes Rivas‐Lasarte, Tuukka Tarvasmäki, Veli‐Pekka Harjola, Benjamin Deniau, Mari Hongisto, Ewa A. Jankowska, Raija Jurkko, Toni Jäntti, Anu Kataja, Alexandre Mebazaa, Tuija Sabell, Alessandro Sionis, Johan Lassus   +14 more
wiley   +1 more source

Ventricular assist device implantation in children with a mechanical valve: An ACTION registry analysis. [PDF]

JHLT Open
Hussain SF, Miller E, Aljohani O, Auerbach S, Bearl D, Benvenuto V, Bonura E, Crawford RL, Joong A, Dyal J, Hartje-Dunn C, Jana S, Kaushal S, Lynn M, Spinner J, Radel L, Raskin A, Torpoco-Rivera D, Wilkens SJ, Villa CR.   +19 more
europepmc   +1 more source

Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure [PDF]

, 2000
Paul M. Heerdt, Jeffrey W. Holmes, Bolin Cai, Alessandro Barbone, John D. Madigan, Steven Reiken, David L. Lee, Mehmet C. Öz, Andrew R. Marks, Daniel Burkhoff   +9 more
openalex   +1 more source

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy

ESC Heart Failure, EarlyView.
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite, Johanna Mueller‐Leisse, Henrike A.K. Hillmann, Stephan Hohmann, Jörg Eiringhaus, Udo Bavendiek, Tibor Kempf, Christian Veltmann, Johann Bauersachs, David Duncker, D. Berliner   +10 more
wiley   +1 more source

Alterations in Ca2+ cycling proteins and Gαq signaling after left ventricular assist device support in failing human hearts [PDF]

, 2000
Yasuchika Takeishi
openalex   +1 more source